{'fraction_non_alphanumeric': 0.022966507177033493, 'fraction_numerical': 0.009569377990430622, 'mean_word_length': 4.811111111111111, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Suppressive T cell function of Epstein-Barr virus induced B cell activation in active Behçet's disease.

B and T cell function were studied in 10 patients with active Behçet's disease (BD) and in 10 normal subjects. Peripheral B lymphocytes infected with Epstein-Barr virus (EBV) were cultured for 20 days in the presence or absence of autologous T cells. Immunoglobulin M and G secretions into the supernatants were assessed with an enzyme-linked immunosorbent assay. The extent of suppression of EBV-induced B cell activation by autologous T cells was significantly decreased in active BD patients as compared to normal subjects at a T:B ratio of 1:1, whereas the suppression ratio was in the normal range at a T:B ratio of 4:1. The IgM and IgG secretions in purified B cell cultures were significantly higher in active BD patients as compared to control subjects. Thus, an increased B cell function associated with a defective EBV-specific T cell suppressive function could explain at least in part the immunological disorders in BD patients.